Drug Profile
Nebivolol - Janssen
Alternative Names: Bystolic; Lobivon; Nebilet; Nebilox; Nebivolol hydrochloride; R 067555; R 65824; R 67555; SolistarLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Janssen L.P.
- Developer AbbVie; Allergan; Duncan; Forest Laboratories; Janssen; Menarini
- Class Antihypertensives; Benzopyrans; Ethanolamines; Fluorobenzenes; Heart failure therapies; Small molecules
- Mechanism of Action Beta 1 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Chronic heart failure; Heart failure; Hypertension
- Discontinued Angina pectoris